Disclosures & 2016 Vanja Douglas, MD None Sara & Evan - - PDF document

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures & 2016 Vanja Douglas, MD None Sara & Evan - - PDF document

5/26/16 Neurology Headlines from 2015 Disclosures & 2016 Vanja Douglas, MD None Sara & Evan Williams Foundation Endowed Neurohospitalist Chair Associate Professor of Clinical Neurology UCSF Department of Neurology Neurohospitalist


slide-1
SLIDE 1

5/26/16 1

Neurology Headlines from 2015 & 2016

Vanja Douglas, MD Sara & Evan Williams Foundation Endowed Neurohospitalist Chair Associate Professor of Clinical Neurology UCSF Department of Neurology Neurohospitalist Program

Disclosures

None

Objectives

  • Describe the treatments available for acute

ischemic stroke

  • Compare and contrast carotid endarterectomy

and stenting

  • Explain why TIA should be treated urgently
  • Discuss evidence-based treatments for back pain
  • List treatment options for agitation in dementia
  • Identify emerging treatments for migraine
  • Effectively examine patients with possible

concussion

Case

  • 73 y/o man with sudden onset right sided

weakness and aphasia

  • Eating breakfast with wife at 9:00 AM
  • Arrived in ED at 9:55 AM
slide-2
SLIDE 2

5/26/16 2

Which of the following is NOT an evidence-based treatment option for this patient?

  • Intravenous tissue plasminogen activator (IV

tPA)

  • Intra-arterial tPA
  • Mechanical embolectomy
  • Combination of IV tPA and mechanical

embolectomy

  • Clopidogrel

Acute Stroke Management

  • IV tPA: 0 to 3 hours
  • IV tPA: 3 to 4.5 hours*
  • Embolectomy: 0 to 6 hours
  • Clock starts:

– Last seen normal

*Not FDA approved; approved in Europe

Image By Sun Ladder - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=10959166

Acute Stroke Management

  • IV tPA: 0 to 3 hours

– 39% no disability vs. 26% no disability – Number needed to treat: 7

  • IV tPA: 4 to 4.5 hours

– 52% no disability vs. 45% no disability – NNT : 14

Jauchet al, Stroke 2013 Public Domain, https://commons.wikimedia.org/w/index.php?curid=244840 9

Acute Stroke Management

  • Embolectomy: 0 to 6 hours

– Large vessel occlusions only (20% of all ischemic stroke patients) – 19-40% independent vs. 33-71% independent – NNT 3 to 7.5

  • Up to 12 hours for basilar occlusions

Powers et al, Stroke 2015

slide-3
SLIDE 3

5/26/16 3

Non-contrast CT head 10:03 AM CT Angiogram Groin puncture 11:40 AM

slide-4
SLIDE 4

5/26/16 4

TICI 3 recanalization: 12:13 PM 4 days post-thrombectomy: Mild right hemiparesis

Case

  • During the angiogram, 80% narrowing of the

left internal carotid artery is confirmed.

  • The 73 y/o patient asks what he can do to

prevent a future stroke.

In which patient is carotid stenting NOT an evidence-based alternative to endarterectomy?

  • 64 year-old woman with 80% stenosis
  • 64 year-old man with 80% stenosis
  • 76 year-old man with 80% stenosis
  • 71 year-old man with 80% stenosis and prior

neck radiation and NYHA Class III heart failure

slide-5
SLIDE 5

5/26/16 5

Symptomatic Carotid Stenosis

Roffiet al., Eur Heart J 2009

Carotid Endarterectomy

Rothwell et al., Lancet 2003

Endarterectomy vs. Stenting

  • Increased odds of stroke or death within 30

days of treatment with stenting

– OR 1.72 (1.29-2.31)

  • Equivalent risk of stroke during follow up

– OR 0.93 (0.60-1.45)

  • Risk difference only seen in patients >70 years

– <70: OR for stenting 1.16 (0.80-1.67) – ≥70: OR for stenting 2.20 (1.47-3.29)

Bonatiet al., Cochrane Database Syst Rev 2012

Endarterectomy vs. Stenting: 10 year follow-up

  • Stroke or

periprocedural death

– Stenting: 98 (11.0%) – CEA: 71 (7.9%) – Hazard ratio 1.37 (1.01 – 1.86)

  • All risk difference

seen in patients 70 and older

B Stroke or Death

Patients (%) 100 80 60 40 20 1 2 3 4 5 6 7 8 9 10 Follow-up (yr)

  • No. at Risk

Endarterectomy Stenting 1240 1262 1127 1111 1056 1049 967 979 848 889 744 777 703 741 624 679 442 479 245 265 67 68 20 Stenting Endarterectomy 15 10 5 1 2 3 4 5 6 7 8 9 10

Brott et al., NEJM 2016; Howard et al., Lancet 2016

slide-6
SLIDE 6

5/26/16 6

Case

  • You are called to admit a patient who

experienced 2 hours of right arm weakness and trouble speaking earlier in the day. He was normal by the time he got to the ED. He is a 63 year-old man with hypertension and diabetes, taking aspirin, lisinopril, and metformin.

  • Blood pressure at triage was 150/85.

TIA: Unstable Angina of the Brain

  • 10% will have a stroke in 90 days
  • Half of these will occur in the first 2 days
  • Is there a way to identify who is at highest

risk?

  • Is there anything you can do to prevent stroke

after TIA?

High Risk TIA: The ABCD2 Score

Clinical Features Points Age ≥ 60 1 point Blood pressure ≥ 140/90 1 point Clinical Symptoms Speech impairment without weakness Unilateral weakness 1 point 2 points Diabetes 1 point Duration 10 to 59 minutes ≥ 60 minutes 1 point 2 points

Johnston et al, Lancet 2007

ABCD2 Score

Johnston et al, Lancet 2007

slide-7
SLIDE 7

5/26/16 7

Modifying Recurrence Risk

Rothwell et al, Lancet 2007

Ama re nco P e t a

  • l. N E

ngl J Me d 2 0 1 6 ;3 7 4 :1 5 3 3 -1 5 4 2 .

Cumulative Incidence of the Composite Outcome in the Overall Population.

A Role for Dual Antiplatelet Therapy?

  • CHANCE:

– 5,170 patients within 24 hours of TIA or minor stroke – Aspirin for 90 days vs. clopidogrel (300 mg loading dose followed by 75 mg daily) for 90 days combined with aspirin 75 mg for 21 days – 8.2% vs. 11.7% with stroke at 90 days – Favored combination therapy; HR 0.68 (p<0.001)

  • POINT Trial ongoing

Wang et al, NEJM2013

TIA: Unstable Angina of the Brain

  • Work up and treat emergently; admit if

necessary to expedite workup

  • Treatment

– Antiplatelets, anticoagulation or endarterectomy Risk factor modification

  • Consider dual antiplatelet therapy for 21 days
slide-8
SLIDE 8

5/26/16 8

Case

  • A 47 year-old man presents to your office with

several days of severe low back pain.

  • He has a history of chronic low back pain for

the past 5 years.

  • His neurological examination is normal.

Which of the following is an evidence- based therapy for acute low back pain?

  • Physical therapy
  • Naproxen
  • Oxycodone
  • Naproxen + cyclobenzaprine

Low Back Pain in the ED

323 patients randomized

Naproxen 9.8 (7.9-11.7) Naproxen + cyclobenzaprine 10.1 (7.9-12.3) Naproxen +

  • xycodone/acetaminophen

11.1 (9.0-13.2) Improvement on RMDQ at 1 week

Friedman et al., JAMA 2015

Physical therapy? Wait a month.

PT x4 weeks (n=108) 3 months: ODI 41.3 -> 6.6 1 year: ODI 7.0 Education & No PT x4 weeks (n=112) 3 months: ODI 40.9 -> 9.8 1 year: ODI 9.0

Fritz et al., JAMA 2015

slide-9
SLIDE 9

5/26/16 9

Do you prescribe steroids for acute radicular pain due to lumbar disk herniation (sciatica)?

  • Yes
  • No

Steroids for Sciatica?

Steroids (n=181; baseline ODI 51.2)

3-week ODI 32.2 1 year ODI 13.4

Placebo (n=88); baseline ODI 51.1)

3-week ODI 37.5 1 year ODI 20.7

Goldberg et al., JAMA 2015; image from Wikimedia Commons

No significant change in pain No difference in surgery rates

For Low Back Pain, Treat the Brain

  • 342 patients randomized to

– Mindfulness based stress reduction – Cognitive behavioral therapy – Usual care

Cherkinet al., JAMA 2016 Richmond et al., PLOS One 2015

slide-10
SLIDE 10

5/26/16 10

Case

  • One of your 84 year-old patients with

Alzheimer Dementia is brought in by his wife for an urgent appointment.

  • In the past several months he has become

paranoid, aggressive and occasionally agitated.

Which of the following is associated with excess mortality when used in patients with dementia?

  • Donepezil
  • Citalopram
  • Valproate
  • Dextromethorphan-Quinidine
  • Quetiapine
  • 220 patients randomized
  • Uncertain clinical benefit but…
  • Improvement on multiple outcome

measures

  • Serious adverse events:
  • 7.9% with dextromethorphan
  • 4.7% with placebo

Cummings et al., JAMA 2015

Case

  • A 56 y/o woman comes to your office

complaining of headaches. She has 4 severe headaches per month and usually misses 2 days of work per month as a result.

  • Sumatriptan works well for the headaches but

sometimes she runs out before she is eligible for refills.

slide-11
SLIDE 11

5/26/16 11

Which of the following are NOT evidence based prophylactic therapies for migraine headaches?

  • Valproate
  • T
  • piramate
  • Propranolol
  • Verapamil
  • Metoprolol
  • Petasites (butterbur)
  • Amitriptyline
  • Riboflavin
  • Venlafaxine
  • Gabapentin

Change in Headache Days: Episodic Migraine

Bigalet al., Lancet Neurol2015

Change in Headache Days: Chronic Migraine

Bigalet al., Lancet Neurol2015

Bonus Case

  • A 19 year-old college student comes into your
  • ffice the day after hitting his head against the

goalpost during soccer practice. There was no loss of consciousness.

  • He is complaining of a headache and is

worried he had a concussion that may affect his performance on his upcoming final exams.

  • He has a history of migraines.
slide-12
SLIDE 12

5/26/16 12

Post- concussive Baseline

  • Orthostatic vitals
  • Head/neck exam

– Cervical ROM & proprioception – Spurling’s maneuver

  • Cognitive assessment

– Orientation – 5-item delayed recall – Concentration: reverse digit span and months backward

  • Mood/affect
  • Cranial nerves I, VII
  • Eyes

– Smooth pursuits & saccades – Convergence (wnl = 6-10 cm) – Nystagmus

  • Vestibular

– Head impulse test – Dynamic visual acuity

  • Cerebellar
  • UMN weakness screen

– Pronator drift – Finger & foot taps – Distal extensor power

Matuszak et al., Sports Health 2016

References

  • Meta-Analysis of Endovascular Thrombectomy after Large-vessel ischemic Stroke:

Goyal M et al. Lancet 2016 Apr 23;387(10029):1723

  • Long-T

erm Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis: Brott TG et al., N Engl J Med 2016 Mar 17; 374(11):1021

  • One-Year Risk of Stroke after TIA or Minor Stroke: AmarencoP et al., N EnglJ Med

2016 Apr 21; 374(16):1533

  • Naproxen with Cyclobenzaprine or Oxycodone for Acute Low Back Pain: Friedman

BW et al., JAMA 2015;314(15):1572

  • Early PT for Acute Low Back Pain: Fritz JM et al., JAMA 2015;314(14):1459
  • Oral Steroids for Sciatica: Goldberg H et al., JAMA2015;313(19):1915
  • Mindfulness and Cognitive Behavioral Therapy for Back Pain: CherkinDC et al.,

JAMA 2016; 315(12):1240

  • Dextromethorphan-Quinidine on Agitation in Patients with AD: Cummings et al.,

JAMA 2015;314(12):1242

  • CGRP Antibody for Migraine: BigalME et al., Lancet Neurol2015;14:1081
  • A Practical Concussion Physical Examination T
  • olbox: Matuszak JM et al., Sports

Health 2016 Mar 28; 8:260

EXTRA SLIDES

slide-13
SLIDE 13

5/26/16 13

Criteria for High CEA Risk – Stenting may be Preferred

Severe comorbidities

  • class III/IV congestive heart

failure

  • class III/IV angina
  • left main CAD
  • >/= 2 vessel CAD
  • left ventricular ejection

fraction </=30%

  • recent MI
  • severe lung disease
  • severe renal disease

Challenging technical or anatomic factors

  • prior neck operation (ie., radical

neck dissection) or neck irradiation

  • postendarterectomy

restenosis

  • surgically inaccessible lesions (ie.,

above C2, below the clavicle)

  • contralateral carotid occlusion
  • contralateral vocal cord palsy
  • presence of a tracheostomy

Kernanet al, Stroke 2014